Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Diffusion Pharmaceuticals stock

Learn how to easily invest in Diffusion Pharmaceuticals stock.

Diffusion Pharmaceuticals Inc is a biotechnology business based in the US. Diffusion Pharmaceuticals shares (DFFN) are listed on the NASDAQ and all prices are listed in US Dollars. Diffusion Pharmaceuticals employs 16 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in Diffusion Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DFFN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Diffusion Pharmaceuticals stock price (NASDAQ: DFFN)

Use our graph to track the performance of DFFN stocks over time.

Diffusion Pharmaceuticals shares at a glance

Information last updated 2022-10-03.
Latest market close$5.66
52-week range$5.10 - $25.73
50-day moving average $6.50
200-day moving average $9.88
Wall St. target price$24.75
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-11.70

Buy Diffusion Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Diffusion Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Diffusion Pharmaceuticals price performance over time

Historical closes compared with the close of $5.66 from 2022-10-04

1 week (2022-09-29) 5.17%
1 month (2022-09-02) -11.01%
3 months (2022-07-06) -17.85%
6 months (2022-04-02) N/A
1 year (2021-10-06) 1,098.90%
2 years (2020-10-06) 530.99%
3 years (2019-10-04) 216.20%
5 years (2017-10-05) 210.99%

Diffusion Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -24.91%
Return on equity TTM -63.49%
Profit margin 0%
Book value $13.08
Market capitalisation $11 million

TTM: trailing 12 months

Diffusion Pharmaceuticals share dividends

We're not expecting Diffusion Pharmaceuticals to pay a dividend over the next 12 months.

Have Diffusion Pharmaceuticals's shares ever split?

Diffusion Pharmaceuticals's shares were split on a 1:50 basis on 18 April 2022. So if you had owned 50 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Diffusion Pharmaceuticals shares – just the quantity. However, indirectly, the new 4900% higher share price could have impacted the market appetite for Diffusion Pharmaceuticals shares which in turn could have impacted Diffusion Pharmaceuticals's share price.

Diffusion Pharmaceuticals share price volatility

Over the last 12 months, Diffusion Pharmaceuticals's shares have ranged in value from as little as $5.1 up to $25.73. A popular way to gauge a stock's volatility is its "beta".

DFFN.US volatility(beta: 1.52)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Diffusion Pharmaceuticals's is 1.5162. This would suggest that Diffusion Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Diffusion Pharmaceuticals overview

Diffusion Pharmaceuticals Inc. , a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia. .

Frequently asked questions

What percentage of Diffusion Pharmaceuticals is owned by insiders or institutions?
Currently 0.2% of Diffusion Pharmaceuticals shares are held by insiders and 10.506% by institutions.
How many people work for Diffusion Pharmaceuticals?
Latest data suggests 16 work at Diffusion Pharmaceuticals.
When does the fiscal year end for Diffusion Pharmaceuticals?
Diffusion Pharmaceuticals's fiscal year ends in December.
Where is Diffusion Pharmaceuticals based?
Diffusion Pharmaceuticals's address is: 300 East Main Street, Charlottesville, VA, United States, 22902
What is Diffusion Pharmaceuticals's ISIN number?
Diffusion Pharmaceuticals's international securities identification number is: US2537484048
What is Diffusion Pharmaceuticals's CUSIP number?
Diffusion Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 001053691

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site